Vogenx, Inc.
VOGX · NASDAQ · USD
$18.65
+1.16 6.63%todayNot financial advice.
- Open
- 17.29
- Day range
- 17.29 - 19.17
- 52-week range
- 12.95 - 38.41
- Volume
- 47.42K
- Market cap
- 277.05M
- P/E ratio
- —
- EPS
- —
- Dividend yield
- 0.00%
- Beta
- -37.03
Performance
W
−6.09%
1M
−41.06%
3M
+43.46%
6M
+43.46%
YTD
+43.46%
Y
+43.46%
5Y
+43.46%
All
+43.46%
In the news
Oct 9
Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Vogenx, Inc. appointed board member Richard Gorman as CCO to lead commercial planning and licensing for its lead drug candidate.
Company news
Oct 9
Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Vogenx, Inc. has named board member Richard Gorman as Chief Commercial Officer to lead the commercial strategy for its lead drug candidate, mizagliflozin.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-VOGX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Vogenx, Inc. (VOGX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-VOGX">VOGX stock price</a> by FreeTheAI Stocks</p>